On the heels of its FDA approval, clinicians weigh in on acoltremon’s (Tryptry) novel mechanism of action and its potential ...

Infuzide, a newly synthesized compound, shows potent activity against drug-resistant microbes, offering new hope in the fight against AMR.

The defects in molecular and cellular processes that constitute the triggers of specific pathologies are referred to as mechanisms of disease. Research in this area is vital for designing ...